S100A1 and neoplasm: Proteins with altered expression levels are involved in tumor immunity (e.g., S100A family members61), epithelial cell differentiation (e.g., CDSN), and EMT (vimentin38,62), suggesting possible selective pressure for immune evasion and cell state plasticity.